Internal Medicine, Rheumatology · Reno, NV
NPI
1770999799
Since 2014
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
10539 Professional Cir Ste 200
Reno, NV, 89521
Phone (775) 445-5193
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
659 services
Medicare patients, 2024
226
Average age 74
Drug cost, 2024
$2.1M
1,783 prescriptions
Company payments, 2025
$1,699
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anjani Pillarisetty was code 99214 (office e&m - established), 407 times for 180 patients. In total Anjani Pillarisetty billed 659 services in 14 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 407 | 180 | $98.87 | $40K |
| 99204 Office E&M - New | Office | 73 | 73 | $132.78 | $9,693 |
| 99215 Office E&M - Established | Office | 63 | 46 | $140.42 | $8,846 |
| 99205 Office E&M - New | Office | 37 | 37 | $166.17 | $6,148 |
| 99213 Office E&M - Established | Office | 26 | 25 | $70.32 | $1,828 |
By year: 2022 $48K for 480 services; 2023 $30K for 283 services; 2024 $68K for 659 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anjani Pillarisetty prescribed most often to Medicare patients was Prednisone, with 255 prescriptions and refills. In total Anjani Pillarisetty wrote 1,783 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 255 | 365 | 110 | $2,075 |
| Hydroxychloroquine Sulfate Generic | 242 | 516 | 73 | $11K |
| Methotrexate Methotrexate Sodium | 195 | 392 | 58 | $6,901 |
| Alendronate Sodium Generic | 97 | 238 | 30 | $812 |
| Meloxicam Generic | 79 | 164 | 30 | $374 |
| Leflunomide Generic | 75 | 170 | 24 | $5,607 |
| Allopurinol Generic | 60 | 159 | 22 | $695 |
| Mycophenolate Mofetil Generic | 59 | 101 | 13 | $4,704 |
| Enbrel Sureclick Etanercept | 58 | 59 | 13 | $430K |
| Colchicine Generic | 40 | 62 | 18 | $2,256 |
| Gabapentin Generic | 38 | 70 | 14 | $542 |
| Amlodipine Besylate Generic | 29 | 59 | Under 11 | $98.96 |
| Tramadol Hcl Generic | 29 | 29 | Under 11 | $182 |
| Methylprednisolone Generic | 28 | 29 | 16 | $178 |
| Orencia Clickject Abatacept | 26 | 26 | Under 11 | $147K |
Brand drugs: 301 claims; generic drugs: 1,482 claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anjani Pillarisetty $1,699 ($1,699 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $366.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $366 |
| Janssen Biotech, Inc. JNJ | 16 | $334 |
| GlaxoSmithKline, LLC. GSK | 10 | $230 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $212 |
| Amgen Inc. AMGN | 5 | $126 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $102 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $98.23 |
| UCB, Inc. UCB.BR | 3 | $64.45 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $46.08 |
| Aurinia Pharma U.S., Inc. AUPH | 2 | $40.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.